EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

GLP‐1 agonist‐associated presentations to unscheduled care: An opportunistic pilot study

Oliver Thomas iD, James Michael Coulson

British Journal of Clinical Pharmacology · 2026

DOI: 10.1002/bcp.70335 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift British Journal of Clinical Pharmacology, 2026. Verfasst von Oliver Thomas und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cardiff & Vale University Health Board, University Hospital of Wales, Heath Park Campus, Cardiff, UK. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Glucagon-Like Peptide 1, Glucagon-Like Peptide-1 Receptor Agonists, Emergency Service, Hospital. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The impact of GLP‐1 or GIP/GLP‐1 receptor agonist use on unscheduled care is not well‐described. We conducted a prospective, observational study using opportunistic screening by clinicians as a first step to understanding the effect of GLP‐1 or GIP/GLP‐1 agonists on Emergency Department presentations and to guide future studies. Data were collected from April to August 2025 at a single centre for any nontrauma adult patient who self‐reported GLP‐1 or GIP/GLP‐1 agonist exposure. Fifty‐six cases were identified, 51 reported tirzepatide use, three subcutaneous semaglutide, one oral semaglutide and one dulaglutide. In 79% of cases (CI95% 66% to 88%), the presenting features were due to GLP‐1 or agonist use. Presentations were greatest in the lowest and highest deprivation quintiles and a significant number had coexisting depression. There is a need for formal observational studies to assess the impact of GLP‐1 or GIP/GLP‐1 agonists on unscheduled care and explore these tentative associations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoglycemic AgentsGlucagon-Like Peptide 1Glucagon-Like Peptide-1 Receptor AgonistsEmergency Service, HospitalDiabetes Mellitus, Type 2HumansPilot ProjectsMaleFemaleMiddle AgedProspective StudiesGlucagon-Like PeptidesAgedRecombinant Fusion ProteinsAdultImmunoglobulin Fc FragmentsGastric Inhibitory PolypeptideSemaglutide

Stichwörter der Autor:innen

GIP/GLP‐1GLP‐1 receptor agonistunscheduled care

Substanzen

Glucagon-Like PeptidesHypoglycemic AgentsGlucagon-Like Peptide 1Glucagon-Like Peptide-1 Receptor AgonistsRecombinant Fusion ProteinsImmunoglobulin Fc FragmentsGastric Inhibitory PolypeptideSemaglutidedulaglutide

Autor:innen und Institutionen

  • Cardiff & Vale University Health Board, University Hospital of Wales, Heath Park Campus, Cardiff, UK.
  • All Wales Therapeutics & Toxicology Centre, Cardiff & Vale University Health Board, University Hospital, Llandough, Penarth, UK.
  • School of Medicine, Cardiff University, Cardiff, UK.

ORCID-Profile: Oliver Thomas

Zitieren

APA

Thomas, O., & Coulson, J. M. (2026). GLP‐1 agonist‐associated presentations to unscheduled care: An opportunistic pilot study. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70335

Vancouver

Thomas O, Coulson JM. GLP‐1 agonist‐associated presentations to unscheduled care: An opportunistic pilot study. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70335

BibTeX
@article{Thomas2026,
  author = {Thomas, Oliver and Coulson, James Michael},
  title = {GLP‐1 agonist‐associated presentations to unscheduled care: An opportunistic pilot study},
  journal = {British Journal of Clinical Pharmacology},
  year = {2026},
  doi = {10.1002/bcp.70335}
}
Kostenlos starten →